Abstract: A lancing device and lancet are provided with depth-control, lancet ejection, and/or guidance mechanisms. The depth-control mechanism includes a dial rotationally mounted at a distal end of the housing of the lancing device, the dial being coupled to a linkage whereby rotation of the dial imparts translational movement to a stop surface of the linkage to limit the stroke of the lancet and thereby control lancing penetration depth. The ejection mechanism includes an ejector that is advanced into contact with a transversely flared flange of the lancet to discharge the lancet from the lancing device. The guidance mechanism includes an inner guidance housing for restricting out-of-axis movement of a lancet carrier.

Abstract: The present invention relates to materials, coatings, apparatus, and methods for removing radiocontrast agent from a patient. In accordance with one aspect of the invention, molecular imprinting technologies are utilized to create a safe, predictable and reliable medium for removal of nephrotoxic contrast agent from body fluids of a patient, such as the bloodstream. In accordance with certain aspects of the present invention, the contrast agent can be removed without mechanical filtering or any other mechanically damaging technique affecting the blood matrix. The molecularly imprinted medium (MIM) can be used to extract the contrast agent from the blood either intra- or extracorporeally.

Abstract: The present invention provides a number of compositions, including non-alcoholic and non-fermented aqueous solutions comprising trans-resveratrol and/or other polyphenols. In one aspect, the present invention provides retail or commercially available beverages comprising trans-resveratrol and/or other polyphenols.